Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States11Funding source: The US Office of Management and Budget (0925-0046).-Reference-Cited by-同舟云学术

Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States11Funding source: The US Office of Management and Budget (0925-0046).

Published:2014-07 Issue:5 Volume:32 Page:637-644
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Apolo Andrea B.,Kim Joseph W.,Bochner Bernard H.,Steinberg Seth M.,Bajorin Dean F.,Kevin Kelly Wm.,Agarwal Piyush K.,Koppie Theresa M.,Kaag Matthew G.,Quinn David I.,Vogelzang Nicholas J.,Sridhar Srikala S.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Bladder cancer: epidemiology, staging and grading, and diagnosis;Kirkali;Urology,2005

3. Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer;Skinner;J Urol,1984

4. Defining optimal therapy for muscle invasive bladder cancer;Herr;J Urol,2007

5. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial;International Collaboration of T;J Clin Oncol,2011

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma;Frontiers in Pharmacology;2024-03-20

2. Plant-Derived Sulforaphane Suppresses Growth and Proliferation of Drug-Sensitive and Drug-Resistant Bladder Cancer Cell Lines In Vitro;Cancers;2022-09-26

3. Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything;Nature Reviews Urology;2022-08-02

4. The utilization status of neoadjuvant chemotherapy in muscle-invasive bladder cancer: a systematic review and meta-analysis;Minerva Urology and Nephrology;2021-05

5. The utilization status of neoadjuvant chemotherapy in muscle-invasive bladder cancer: a systematic review and meta-analysis;MINERVA UROL NEPHROL;2021